Pacylex announced that CEO Michael Weickert will present an update on clinical progress of PCLX-001 and Series B plans for Pacylex Pharmaceuticals at Biotech Showcase™ 2023.
"We are delighted to be presenting again at Biotech Showcase, which has always been an important venue to start our New Year. This year is more important than ever as we have made great progress in patients and are raising capital for two efficacy studies in blood cancers that could prove pivotal." said Michael Weickert, CEO of Pacylex.
Read the full press release here.